Prof Suneil Jain

Suneil Jain is a Professor of Clinical Oncology at Queens University Belfast and Consultant Clinical Oncologist at the Northern Ireland Cancer Centre. His research interests include radiomic and genomic biomarkers to improve risk stratification in prostate cancer, the utilisation of nanotechnology to enhance the effects of radiation therapy, stereotactic radiotherapy and systemic therapies in prostate cancer. He is Chief Investigator on the SABRE phase III clinical trial evaluating SpaceOAR Vue in patients treated with stereotactic radiotherapy and Clinical Lead for the PACE NODEs phase III clinical trial. He is Co-Director of the Prostate Cancer Centre of Research Excellence at QUB.